Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
90 participants
INTERVENTIONAL
2025-11-10
2028-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To examine the effect of at-home taste and smell training versus standard care on taste function and other outcome parameters, measurements will take place at baseline (before the training starts), and after 12 weeks. The intervention will take place at home. The control group will receive usual care. Questionnaires will be filled in online at home, while taste and smell tests and saliva collection will be conducted either at home or in the hospital during regular visits. Patients in both study arms are contacted by their dietitian every 3 weeks.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Endurance Exercise and Histamine Receptors on the Gene Expression in Skeletal Muscle
NCT05131555
Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects
NCT01477619
Healthy Aging Through Dietary Intervention
NCT05782309
The Role of Histamine in Muscle Protein Synthesis Following Resistance Training
NCT06152497
Helping Olfaction and Nutrition On Renal Replacement
NCT02479451
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Taste and smell training
To examine the effect of at-home taste and smell training versus standard care on taste function and other outcome parameters, measurements will take place at baseline (before the training starts), and after 12 weeks. The intervention will take place at home.
Taste and smell training
To examine the effect of at-home taste and smell training versus standard care on taste function and other outcome parameters, measurements will take place at baseline (before the training starts), and after 12 weeks. The intervention will take place at home. The control group will receive usual care. Questionnaires will be filled in online at home, while taste and smell tests and saliva collection will be conducted either at home or in the hospital during regular visits. Patients in both study arms are contacted by their dietitian every 3 weeks.
No intervention
Standard of care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Taste and smell training
To examine the effect of at-home taste and smell training versus standard care on taste function and other outcome parameters, measurements will take place at baseline (before the training starts), and after 12 weeks. The intervention will take place at home. The control group will receive usual care. Questionnaires will be filled in online at home, while taste and smell tests and saliva collection will be conducted either at home or in the hospital during regular visits. Patients in both study arms are contacted by their dietitian every 3 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intention of being treated with tyrosine kinase inhibitors for next 12 weeks.
* Experiencing taste alterations after starting treatment with tyrosine kinase inhibitors
* Consuming solid foods and drinks is possible
* ≤50% of recommended daily intake in kcal consisting of oral nutritional supplements
* Oral mucositis grade ≤2 (Common Terminology Criteria for Adverse Events, version 5.0)
* Ability to comply with all protocol-required actions
* Written informed consent
Exclusion Criteria
* History of taste, smell, or saliva production dysfunction before treatment with tyrosine kinase inhibitors
* Previous or current radiotherapy of head and neck region
* Enteral feeding through tube or parenteral feeding
* Participation in another clinical trial aimed at preventing or treating taste and/or smell alterations
* Chronic (\>1 month) high dose corticosteroids (\>10 mg prednisone/day or equivalent)
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Center Groningen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
J. J.A. de Haan, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Medical Center Groningen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam UMC
Amsterdam, , Netherlands
Rijnstate Ziekenhuis
Arnhem, , Netherlands
Van Weel-Bethesda Ziekenhuis
Dirksland, , Netherlands
Ziekenhuisvoorzieningen Gelderse Vallei
Ede, , Netherlands
University Medical Center Groningen
Groningen, , Netherlands
Martini Ziekenhuis
Groningen, , Netherlands
Radboud University medical Center
Nijmegen, , Netherlands
Ikazia Ziekenhuis
Rotterdam, , Netherlands
Ommelander Ziekenhuis Groningen
Scheemda, , Netherlands
Maxima Medisch Centrum
Veldhoven, , Netherlands
Isala Klinieken
Zwolle, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
K. Silverio Alonso-Duin
Role: primary
M. D.J.L. van der Vorst
Role: primary
H. Noordzij-Nooteboom
Role: primary
G. A. Velders
Role: primary
A. W.G. van der Velden
Role: primary
S. Kaal
Role: primary
F. de Boer
Role: primary
T. Osinga-Fickweiler
Role: primary
R. van Lieshout
Role: primary
J. W.B. de Groot
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20901
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.